The Europe in-vitro diagnostics market is expected to grow from US$ 22,616.55 million in 2022 to US$ 34,247.12 million by 2030. It is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Market Introduction

The diagnosis of infectious diseases relies heavily on IVDs, which include immunoassays and molecular assays. During the COVID-19 pandemic, diagnostic companies prioritized accelerating their offerings, a process facilitated by regulatory authorities who temporarily adjusted their standards for new IVD launches. This combination of factors significantly increased the demand for molecular diagnostics and immunoassays. Furthermore, many companies broadened their existing IVD manufacturing product lines.

A notable example of this trend was the British In Vitro Diagnostics Association (BIVDA) launching its "The Digital Revolution" strategy in June 2021 to encourage breakthroughs in in-vitro diagnostics during the pandemic. In another significant development, BioGX announced the CE-marked launch of a three-gene point-of-care (POC) multiplex COVID-19 test on its Pixel platform in July 2022. Consequently, the COVID-19 pandemic has been a boon for the in-vitro diagnostics market, leading to increased demand for both point-of-care (POC) diagnostics and laboratory testing procedures.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00022122

Europe In-Vitro Diagnostics Market Overview

The European in-vitro diagnostics market comprises segments like Germany, France, the UK, Italy, Spain, and the Rest of Europe. The growth of this market is attributed to rising awareness of disease diagnosis, an expanding aging population, and technological advancements in in-vitro diagnostics. Germany leads the European IVD market, recognized for its innovative capabilities, particularly in molecular biology, miniaturization, and automation. The German "Industrie 4.0" project is driving digitalization, especially in IVD, with "Lab 4.0" focusing on efficient data handling and cloud-based systems.

The COVID-19 pandemic triggered a substantial increase in demand for IVDs across Germany. Extensive testing was a cornerstone of the German government's health policy to combat the pandemic. German companies are well-regarded innovators in developing molecular tests, as well as high-tech instruments and consumables used in the bioanalysis of molecular information. Advancements in in-vitro diagnostics, including innovative product launches and the integration of automation systems in labs, are strongly propelling the in-vitro diagnostics market in Germany.

Europe In-Vitro Diagnostics Market Segmentation

The Europe in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Europe in-vitro diagnostics market in 2022.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications